High Court Won't Hear Apotex's Exclusivity Appeal
The U.S. Supreme Court has declined to hear Apotex Inc.'s challenge to a federal appeals court's ruling in favor of Teva Pharmaceuticals USA Inc. that a patent holder's unilateral decisions cannot...To view the full article, register now.
Already a subscriber? Click here to view full article